Company Presents New Method for Rapidly Determining the Effective Antibiotics to Treat Serious Infections Directly from Patient Samples

New facility offers additional space, state of the art laboratory, added manufacturing capacity

Results of Technical Study Presented at ASM Microbe 2018

Describing rapid and accurate immunoassay-based technology capable of counting single molecules using digital imaging without magnification

A contract extension representing $10.7 million over two years

Presenting Their Findings in a Scientific Poster Session at IDWeek

Seasoned Industry Veteran to Take Company Through Next Phase of Development